Выберите действие
avatar

#переведено ИИ

MicroStrategy’s Bitcoin Bet Doubles to $6 Billion as Price Soars

0
61 просмотр

(Bloomberg) -- MicroStrategy Inc. appears to be one of the bigger beneficiaries from the euphoria surrounding the likely launch of Bitcoin ETFs, with the overall value of the company’s holding of the cryptocurrency doubling.

Most Read from Bloomberg

Out-of-Practice Airline Pilots Are Making Errors Back in the Air

The Biggest Public Graveyard in the U.S. Is Becoming a Park

Why Buying a Second or Even Third Home Is Becoming More Popular Than Ever

The World’s Rich and Powerful Are Stashing $500 Billion in This Tax Haven

What Comes After GE’s 129 Years of Greenhouse Gas

The enterprise software firm held approximately 114,042 Bitcoin as of Sept. 12, acquired at an aggregate purchase price of $3.16 billion and an average price of $27,713 per token, inclusive of fees and expenses. That investment is now valued at about $6.7 billion, with the price of the digital currency topping $60,000 Friday as it approached record highs.

Michael Saylor, the founder and chief executive of MicroStrategy began buying Bitcoin in August 2020, saying that it was better to hold the cryptocurrency on the company’s balance sheet rather than cash or low-yielding U.S. securities as most companies tend to do. While controversial, the strategy was later adopted by Tesla Inc. and Square Inc., helping to boost the price of Bitcoin to a record high in April before it turned lower again. Saylor celebrated the rebound Friday on Twitter.

The surge in Bitcoin has also helped to almost double the value of MicroStrategy’s stock this year, giving the company a market value of about $8.6 billion.

Most Read from Bloomberg Businessweek

How Donald Trump, Elon Musk, and Gwyneth Paltrow Short-Circuit Your Ability to Think Rationally

These Out-of-Work Americans Tell Us Job Market Turmoil Is Anything But Transitory

Jane Fraser Has a Plan to Remake Citigroup While Tormenting Rivals

What My Brain Scan Revealed About the Science of Persuasion

Homeopathy Doesn’t Work. So Why Do So Many Germans Believe in It?

©2021 Bloomberg L.P.

Комментарии

0

/ 2500

Раскройте тему

Оставьте первый комментарий